Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
146.5 USD | +0.54% | +0.22% | -6.55% |
07-03 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
07-03 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-6.55% | 351B | |
+56.89% | 809B | |
+39.52% | 624B | |
+7.92% | 289B | |
+13.74% | 240B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 166B | |
-2.57% | 157B | |
+1.31% | 123B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer